The Bariatric Surgery Registry
Launched by MONASH UNIVERSITY · Feb 20, 2018
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
The Bariatric Surgery Registry is a study that aims to gather important information about people who have obesity and are considering weight loss surgery. This surgery can help individuals lose weight and improve their overall health, especially for those who have not had success with traditional weight loss methods. The registry will track patients for ten years after their surgery, collecting details about their weight, any complications that arise, and how their health, particularly diabetes management, changes over time.
To participate, individuals must have a Body Mass Index (BMI) greater than 30, which indicates obesity. Unfortunately, pregnant women cannot join the study. Participants can expect their surgeons or hospitals to provide information to the registry, and they may receive follow-up calls to check on their progress. This registry is important because it will help ensure that surgeries are performed safely and effectively, and it will provide valuable data on how well bariatric surgery works for improving health and quality of life in Australia and New Zealand.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Body Mass Index (BMI) \>30 kg/m2
- Exclusion Criteria:
- • Pregnant women
About Monash University
Monash University, a leading research institution located in Melbourne, Australia, is dedicated to advancing health and medical knowledge through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Monash University leverages its extensive expertise in fields such as medicine, pharmacy, and biomedical sciences to conduct rigorous, ethically sound research aimed at improving patient outcomes. The university is committed to fostering a research environment that supports the translation of scientific discoveries into practical applications, ensuring that its clinical trials contribute meaningfully to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Melbourne, Victoria, Australia
Patients applied
Trial Officials
Ian Caterson, MBBS
Study Chair
Boden Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials